GlaucomaNCT07216677
A Real-World Study of Interventional Clinical Outcomes in Patients With Open Angle Glaucoma and Other Chronic Eye Diseases
An observational study of Glaucoma and AMD, run by Interstat LLC at 1 site in United States.
Trial summary
This is a real world investigation of patient who have undergone treatments for chronic eye conditions such as glaucoma and AMD. Read more about this study
- Who is it for?
- Ages 18 to 99 years
- Conditions the study is for
- Glaucoma, AMD, Diabetic Retinopathy (DR)
- What is being tested?
- Chronic Disease Intervention CDI
- How many people
- 300 participants
- Where
- 1 siteUnited States
- Study dates
- 10 Oct 2024to 25 Oct 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 99 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with a chronic eye disease
Who may be able to join
- Clinical diagnosis of Glaucoma or AMD or Diabetic Retinopathy Recent history of a chronic disease intervention in the prior 6 months
Who cannot join
- Patient who are pregnant lactating younger than 18 years of age unable to execute informed consent.
Trial locations and contacts
1 site in 1 country.
About this study
This is a real world investigation of patient who have undergone treatments for chronic eye conditions such as glaucoma and AMD.
Read the detailed description
The objective of the study is to understand the real-world outcomes after chronic disease treatments for glaucoma and AMD and to compare to reported clinical study outcomes
- Conditions
- Glaucoma, AMD, Diabetic Retinopathy (DR)
- Being tested
- Chronic Disease Intervention CDI
- Keywords
- Glaucoma AMD
- Medical subject headings
- Glaucoma, Diabetic Retinopathy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Chronic Disease Intervention CDIOther
Intervention for the management of a chronic eye disease
| Study group | Role | What they receive |
|---|---|---|
| Post-intervention Observational Group | Not described Receives: Other: Chronic Disease Intervention CDI |
What is being measured
The primary outcome is the main question the study is designed to answer.
Changes in Chronic Disease Interventional outcomes such as Intraocular pressure, best corrected vision and other parameters.
Longitudinal change in interventional chronic disease outcomes
Measured: up to 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Oct 2025
- Study start10 Oct 2024
- Primary completion25 Oct 2027 (estimated)
- Study completion25 Oct 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for GlaucomaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 300 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Interstat LLC
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Tsontcho Ianchulev, Interstat LLC
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07216677
- Sponsor's protocol ID
- CAN-012
- Status last verified
- Oct 2025
- First submitted
- 10 Oct 2025
- Last updated
- 15 Oct 2025
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Oct 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Real-World Study of Interventional Clinical Outcomes in Patients With Open Angle Glaucoma and Other Chronic Eye Diseases
- ClinicalTrials.gov ID
- NCT07216677
- Acronym / sponsor ID
- CAN-012
- Conditions
- Glaucoma, AMD, Diabetic Retinopathy (DR)
- Keywords
- Glaucoma AMD
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- Interstat LLCUniversity, hospital or other
- Study start
- 10 Oct 2024 (actual)
- Primary completion
- 25 Oct 2027 (estimated)
- Study completion
- 25 Oct 2027 (estimated)
- First posted
- 14 Oct 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a real world investigation of patient who have undergone treatments for chronic eye conditions such as glaucoma and AMD.
Detailed description
The objective of the study is to understand the real-world outcomes after chronic disease treatments for glaucoma and AMD and to compare to reported clinical study outcomes
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Post-intervention Observational Group | – | Other: Chronic Disease Intervention CDI |
Who may qualify
- Ages
- 18 to 99 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with a chronic eye disease
Key inclusion criteria (1 listed)
- Clinical diagnosis of Glaucoma or AMD or Diabetic Retinopathy Recent history of a chronic disease intervention in the prior 6 months
Key exclusion criteria (1 listed)
- Patient who are pregnant lactating younger than 18 years of age unable to execute informed consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Chronic Disease Intervention CDIIntervention for the management of a chronic eye disease | Other | Post-intervention Observational Group |
Primary outcome
Changes in Chronic Disease Interventional outcomes such as Intraocular pressure, best corrected vision and other parameters.
Time frame: up to 12 months
Longitudinal change in interventional chronic disease outcomes
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Oct 2025.
- Individual participant dataSharing planned: No
Related trials for Glaucoma
Recruiting
Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
Glaucoma, Ocular Hypertension
Not yet recruiting
AI-Assisted vs Conventional Teleglaucoma Referral
Glaucoma
Recruiting
Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment
Retinitis Pigmentosa (RP), Rod Cone Dystrophy
Recruiting
Automated Applanation Tonometry - Updated
Glaucoma, Glaucoma, Suspect
RecruitingPhase 2
A Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With Glaucoma or High Eye Pressure.
Primary Open - Angle Glaucoma (POAG), Ocular Hypertension (OHT)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Glaucoma and AMD, run by Interstat LLC at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 15 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Changes in Chronic Disease Interventional outcomes such as Intraocular pressure, best corrected vision and other parameters. (time frame: up to 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2025.